Mar 31, 2025
The Aira App: On Demand Expert Assistance
With the Aira app, people with vision loss connect to vetted, live, expertly trained assistants. Using the camera on your smartphone, they walk you through whatever task you’re struggling to…
Resources
Mar 26, 2025
Researchers develop eye drops that slow progressive vision loss in mice
March 24, 2025 By Jordana Joy, Associate Editor Researchers developed eye drop formulations 17-mer and H105A, both containing a short peptide, to administer to mice in the form of a drop…
Mar 24, 2025
Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management
Join Our FREE Webinar! Topic: Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management When: March 26, 2025, at 12 PM EDT Duration: 1 hour Learn how…
Mar 24, 2025
Retinal vein occlusion (RVO) patients to participate in a paid market research study
Opinions Link Research is looking for retinal vein occlusion (RVO) patients to participate in a paid market research study, sharing their opinions on this condition and treatments taken…
Mar 24, 2025
Bausch + Lomb publishes study results on early patient-reported outcomes with Miebo in patients with DED
March 20, 2025, By Jordana Joy, Associate Editor Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline in the severity of overall dry…
Mar 18, 2025
Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double‑Blind Placebo‑Controlled Trial
New Research Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain inChildren: A Randomized Double‑Blind Placebo‑Controlled Trial Karen A. Hecht· Megha Marwah· Vincent Wood· Yasuhiro Nishida· Austin E. Bach· Jeffry…
Mar 18, 2025
Cigarette smoking linked to reduced choroidal vascularity
Author(s): Lynda Charters Key Takeaways Cigarette smoking significantly reduces choroidal vascularity, as indicated by a decreased choroidal vascularity index (CVI). Smoking increases oxidative stress, affecting vascular endothelium and reducing retinal…
Mar 14, 2025
Ozempic is making some patients go blind: ‘Will Ozempic survive this? We’ll see’
By Sarah Caesar | Fact-checked by Barbara Bekiesz | Published March 10, 2025 Industry Buzz “[It’s] important to consider gradually tapering patients onto these drugs. Slowly lowering blood sugar, rather than doing so rapidly, may help reduce…
Mar 14, 2025
Can Vitamins Help Slow Down Macular Degeneration?
Macular degeneration is a progressive eye condition that has no cure. In some cases, a specific combination of nutrients found in supplements called AREDS 2 can slow its progression. Age-related…
Mar 11, 2025
The human impact of geographic atrophy
Author(s): Ophthalmology Times Staff Reports Fact checked by: Sheryl Stevenson Key Takeaways GA significantly impacts patients’ independence, with many reducing activities like driving and hobbies, affecting their sense of self…
Mar 10, 2025
Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD
Author(s): Martin David Harp Ixo-vec utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette and is designed to be administered…
Mar 4, 2025
Astaxanthin (AstaReal®) Improved Acute andChronic Digital Eye Strain inChildren: ARandomized Double‑Blind Placebo‑Controlled Trial
“Our very own medical director, Dr. Jeffry Gerson, is involved with eyecare beyond macular degeneration.” See the latest publication he has been working on: ABSTRACT Introduction: This study assessed the…
Mar 4, 2025
GA lesion location plays role in vision-related quality of life
By: Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: Vision-related quality of life is primarily dependent on the eye with better vision. An analysis found the inner lower…
Mar 4, 2025
Older patients with DME have weaker response to anti-VEGF treatment
By: Alex Young Fact checked by: Christine Klimanskis, ELS Key takeaways: Improvement in visual acuity and central subfield thickness from baseline decreased with older age. Weak treatment response in both…
Mar 3, 2025
“Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy”
Principal Investigator: Jeremiah Brown, Jr., MS, MD It is notable that the rate of progression of geographic atrophy varies amongst patients, amongst lesion types, and amongst lesion patterns. Some patients are…
Mar 3, 2025
Food as medicine: The role of nutrition in eye health
March 3, 2025 By Carrie Roitstein, OD, cPNP, INHC Fact checked by Jordana Joy, Associate Editor Creating a healthier population will require extended efforts by optometrists. The idea of using food as…
Feb 18, 2025
Moderate to severe obstructive sleep apnea tied to higher odds for neovascular AMD
By: Cassandra Jenkins Fact checked by: Heather Biele Key takeaways: Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD. Nocturnal hypoxia may be a…
Feb 17, 2025
COPHy The 16th Annual Congress on Controversies in Ophthalmolgy
COPHy VOD Unlock unparalleled access to the world of ophthalmology! ComtecMed VOD platform is your gateway to the exclusive annual World Congress on Controversies in Ophthalmology (COPHy). With lectures and debates…
Feb 17, 2025
MIND diet ranked no. 1 for brain health
Published February 3, 2025 | Originally published on Newswise: Health Food A diet created by researchers at Rush is ranked among the top diets for 2025 by U.S. News & World Report. Best Diets…
Feb 14, 2025
FDA approves amended label for Izervay for geographic atrophy
February 13, 2025 By Emily Kaiser Maharjan, Assistant Managing Editor The approval follows a refiling after the FDA issued a Complete Response Letter regarding language on the amended label. The FDA…
Feb 11, 2025
Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
February 10, 2025, By Martin David Harp Results were published from the phase 3 QUASAR trial and the extension study of the phase 3 PULSAR trial. Regeneron Pharmaceuticals has announced results…
Feb 11, 2025
February is Low Vision Awareness Month
Did you know that? Statistics show that low vision affects 2.2 billion people globally, and 12 million in the US, impacting their daily lives. Low Vision can result due to…
Feb 10, 2025
Federal Policy Announcements and Discussions about Funding Research
Dear Macular Degeneration Association Friends, The recent federal policy announcements and discussions about funding research have raised questions from our donors about the potential impact on biomedical research.…
Feb 10, 2025
February is Macular Degeneration Awareness Month
Here is important information about macular degeneration, which is known as the number one cause of irreversible blindness and visual impairment in the older population. Age-related macular degeneration (AMD) is…
Feb 4, 2025
Notal Vision publishes positive results from pivotal study of AI algorithm in home-based OCT system
Author(s): Martin David Harp Key Takeaways The AI algorithm demonstrated strong repeatability and agreement with expert graders in segmenting hypo-reflective spaces in nAMD patients. The AI’s repeatability in…
Feb 4, 2025
February is Age-Related Macular Degeneration Month
February is Age-Related Macular Degeneration (AMD) Awareness Month Did you know that there are three forms of age-related macular degeneration? Dry AMD is a…
Feb 4, 2025
Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy
Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy- Research project funded by the Macular Degeneration Association Principal Investigator: …
Feb 3, 2025
Intracranial pressure levels may be a critical factor in glaucoma
Key takeaways: Glaucoma may be a result of two pressures: IOP and intracranial pressure. When one pressure is high and the other is low, it results in ganglion cell proptosis,…
Jan 31, 2025
Opening our eyes to the impact of preservatives
January 30, 2025 By Elyse Rayborn, OD, MBA, FAAO Chris Lievens, OD, MS, FAAO, FNAP Optometry Times JournalJanuary/February digital edition 2025 Preservatives may disrupt the ocular surface, contributing to poor adherence.…
Jan 31, 2025
Are Blueberries Good for Diabetes?
Blueberries are packed with vitamins, antioxidants, and minerals that promote overall health. For people living with diabetes, blueberries may also help with glucose processing, weight loss, and insulin sensitivity. Blueberry…